MAGNI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 17.319
AS - Asia 11.783
EU - Europa 9.992
SA - Sud America 1.744
Continente sconosciuto - Info sul continente non disponibili 572
AF - Africa 367
OC - Oceania 30
Totale 41.807
Nazione #
US - Stati Uniti d'America 16.852
CN - Cina 5.759
SG - Singapore 2.592
IE - Irlanda 2.252
IT - Italia 1.405
BR - Brasile 1.318
RU - Federazione Russa 1.184
HK - Hong Kong 1.116
DE - Germania 1.066
VN - Vietnam 1.052
UA - Ucraina 989
FI - Finlandia 895
FR - Francia 628
GB - Regno Unito 501
SE - Svezia 457
IN - India 316
CA - Canada 239
ZA - Sudafrica 213
AR - Argentina 165
BD - Bangladesh 146
MX - Messico 135
IQ - Iraq 111
BE - Belgio 107
JP - Giappone 103
NL - Olanda 86
PL - Polonia 86
ES - Italia 79
EC - Ecuador 71
TR - Turchia 69
CO - Colombia 64
PK - Pakistan 58
AT - Austria 50
IR - Iran 45
ID - Indonesia 44
VE - Venezuela 43
MA - Marocco 38
UZ - Uzbekistan 38
SA - Arabia Saudita 37
CH - Svizzera 34
MY - Malesia 33
CZ - Repubblica Ceca 32
CL - Cile 31
PH - Filippine 30
JO - Giordania 26
LT - Lituania 23
EU - Europa 22
AU - Australia 21
JM - Giamaica 21
NP - Nepal 20
IL - Israele 19
AE - Emirati Arabi Uniti 18
GR - Grecia 18
TN - Tunisia 18
AZ - Azerbaigian 17
EG - Egitto 16
ET - Etiopia 16
KZ - Kazakistan 16
PE - Perù 16
DO - Repubblica Dominicana 14
RO - Romania 14
BO - Bolivia 13
KE - Kenya 13
KR - Corea 13
CR - Costa Rica 12
DZ - Algeria 12
LV - Lettonia 12
TH - Thailandia 12
AL - Albania 11
UY - Uruguay 11
PY - Paraguay 10
PS - Palestinian Territory 9
QA - Qatar 9
AM - Armenia 8
HR - Croazia 8
LB - Libano 8
OM - Oman 8
KG - Kirghizistan 7
LK - Sri Lanka 7
NI - Nicaragua 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
BG - Bulgaria 6
HN - Honduras 6
HU - Ungheria 6
SN - Senegal 6
BB - Barbados 5
BY - Bielorussia 5
GE - Georgia 5
GT - Guatemala 5
KW - Kuwait 5
NG - Nigeria 5
RS - Serbia 5
CI - Costa d'Avorio 4
DK - Danimarca 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
NO - Norvegia 4
PA - Panama 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 41.179
Città #
Dublin 2.247
Chandler 2.067
San Jose 1.634
Dallas 1.472
Singapore 1.466
Ashburn 1.418
Jacksonville 1.304
Nanjing 1.147
Hong Kong 1.079
Beijing 1.017
Boardman 814
Council Bluffs 623
Nanchang 482
Los Angeles 429
Ho Chi Minh City 383
Princeton 366
Lauterbourg 363
Pavia 362
New York 361
Lawrence 354
Wilmington 347
Ann Arbor 326
Changsha 326
Helsinki 313
Shenyang 310
Hebei 309
Dearborn 304
Medford 303
Hanoi 262
Shanghai 255
Moscow 249
Jiaxing 245
Milan 231
Munich 218
Tianjin 196
Hangzhou 190
Johannesburg 180
Buffalo 176
Redondo Beach 163
São Paulo 137
Santa Clara 135
Orem 121
Toronto 104
Brussels 99
Turku 99
Tokyo 93
Woodbridge 87
Seattle 81
Norwalk 71
Rome 70
Chennai 69
Frankfurt am Main 69
Warsaw 68
Brooklyn 64
London 64
Verona 63
Montreal 62
Atlanta 59
Denver 57
Guangzhou 55
Piscataway 52
Chicago 50
Kunming 49
Mexico City 49
Phoenix 49
Houston 48
Da Nang 47
San Francisco 47
Florence 46
Falkenstein 45
Nuremberg 45
Stockholm 45
Jinan 43
Boston 40
Amsterdam 38
Haiphong 38
Poplar 35
Tashkent 35
Baghdad 34
Mumbai 34
Ningbo 34
Zhengzhou 34
Rio de Janeiro 33
Fairfield 32
Washington 32
Manchester 31
Brasília 29
Des Moines 29
Columbus 27
Quito 26
Dhaka 25
Hefei 25
Vienna 25
Basingstoke 24
Biên Hòa 24
Hải Dương 23
Zurich 23
Belo Horizonte 22
New Delhi 22
Paris 22
Totale 27.429
Nome #
An automatic implementation of ACMG/ClinGen guidelines for constitutional Copy Number Variants annotation and interpretation 213
A comparison of eVai, CADD and VVP variant prediction results on the ICR639 hereditary cancer dataset 210
Living Materials for the Detection of Volatile Compounds to Monitor Agroindustrial Processes 197
Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management 186
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 185
Quantitative evaluation of RC-106 antitumor activity in GBM spheroids through tumor growth inhibition modeling based on cell counts data 180
A Bayesian approach to non-parametric AUC estimation in population studies 170
A Bayesian method for clustering gene expression temporal profiles from microarray data 170
A Markov decision process: screening hereditary hemochromatosis 165
A novel method for proteomic analysis of immunoglobulin light chains and attribution to a germline gene-based family 165
DIVAs: a phenotype-based machine-learning model to assess the pathogenicity of digenic variant combinations 165
Phenotypes extraction from clinical descriptions using Large Language Models 159
Astrazioni temporali per il clustering di profili di espressione genica 158
A non parametric population approach for selecting biomarkers of a drug action 158
An integrative pathology workflow to enhance molecular diagnostics in precision oncology 154
A Perl procedure for the analysis of phosphopeptide tandem mass spectra 151
Clinical classification of myelofibrosis with myeloid metaplasia (MMM): cluster analysis of 861 patients enrolled into a nationwide prospective registry (RIMM) 149
Improving protein identification by MsPI using peak intensity 149
Methods for the analysis of mass spectrometry data in proteomics 149
A standard vector for the chromosomal integration and characterization of BioBrick™ parts in Escherichia coli 148
OPTIMIZATION OF GAMMA-PGA BIOSYNTHESIS SUPPORTED BY SYNTHETIC BIOLOGY AND METABOLIC ENGINEERING STRATEGIES 148
In-Silico and in-Vivo Metabolic Engineering Strategies to Optimize Waste Bioconversion Pathways in Microbial Strains: Two Case Studies on Ethanol and Poly-Gamma-Glutamic Acid Biosynthesis 147
Protein identification by peptide mass fingerprinting: a perl procedure 146
Ethanol? Whey not! 146
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 146
A BioBrick-compatible Vector for Allelic Replacement Using the XylE Gene as Selection Marker 146
Phosphopeptide identification: an automated Perl procedure 145
A Bioinformatics Approach to Explore MicroRNAs as Tools to Bridge Pathways Between Plants and Animals. Is DNA Damage Response (DDR) a Potential Target Process? 144
Evaluation of the T-IDDM Project in Pavia 144
A mathematical model for assessing the glucose time course in critically ill patients 143
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 143
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 142
A data mining approach to evaluate the performance of recruitment centres in antidepressant drug clinical trials 141
A bioinformatic approach to predict the cross-kingdompotential of plant miRNA in humans 141
Integration of enzymatic data in Bacillus subtilis genome-scale metabolic model improves phenotype predictions and enables in silico design of poly-γ-glutamic acid production strains 141
Bottom-up engineering of biological systems through standard bricks: a modularity study on basic parts and devices 140
A Bayesian nonparametric approach to AUC determination in population studies 140
A mathematical model to study the effects of drugs administration on tumor growth dynamics 140
A Perl procedure to improve the efficiency of the identification and characterization of phosphopeptides 139
Characterization of a synthetic bacterial self-destruction device for programmed cell death and for recombinant proteins release 138
A tumor growth inhibition model in drugs combination regimens 137
A procedure to decompose high resolution mass spectra 137
'Indolent' myelofibrosis with myeloid metaplasia: specific clinical features and prognosis 137
A methodology for the reliable analysis of amplicon-based NGS data 137
Integrative analysis of heterogeneous high-throughput transcriptomic data for promoter selection in bacterial genomes to support microbial synthetic biology 136
Learning Gene Regulatory Networks with an Intelligent Data Analysis Approach: An Application to the Yeast Cell Cycle 136
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 136
Movement detection from a wearable system: a deconvolution-based approach 136
Methods and tools for multiscale modelling in Systems Pharmacology: a review 136
Precedence Temporal Networks from Gene Expression Data 135
A Perl procedure for protein identification by Peptide Mass Fingerprinting 135
Bottom-up design of genetic circuits: characterization and re-use of biological building blocks to engineer predictable systems 134
Biologia sintetica e standardizzazione: verso la programmazione razionale di funzioni biologiche artificiali 133
Optimization of γ-PGA biosynthesis supported by synthetic biology and metabolic engineering strategies 132
CRISPR Interference Modules as Low-Burden Logic Inverters in Synthetic Circuits 132
Analisi di dati di DNA microarray: reti di regolazione 131
Genome-wide gene expression in aneurysmal aortic walls of patients with Marfan Syndrome (MFS) and Loeys-Dietz Syndromes (LDS) with known causative mutations 131
Three thiamine analogues differently alter thiamine transport and metabolism in nervous tissues: an in vivo kinetic study using rats 131
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine sources of variability and preliminary observations on relations with clinical response. 129
Learning Rules with Complex Temporal Patterns in Biomedical Domains 129
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 129
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 128
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 128
Characterization of promoter strength varying the DNA copy number from one to hundreds of copy 128
Engineering endogenous fermentative routes in ethanologenic Escherichia coli W for bioethanol production from concentrated whey permeate 128
Analysis of intergenic conserved sequences in the POF critical region on X chromosome 127
Precedence Temporal Networks: a New Tool for Extracting Temporal Relationships in Gene Expression Profiles 127
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 127
Analisi di dati di DNA microarray: fondamenti, selezione di geni, classificazione 127
Modeling myelosuppression in patients treated with anticancer drugs 126
Design and implementation of a negative feedback controller in E. coli with a bottom-up approach 126
Conversion of industrial bio-waste into biofuels through Syntetic Biology supported by flow cytometry 126
Heart rate correction of the QT interval: a nonparametric individualized approach 125
Characterization of a synthetic luxR-HSL repressible promoter for the design of novel activation-repression circuits in E. coli 125
Predicting Aqueous and Intrinsic Solubility of Pharmaceutical Molecules with Neural Networks 125
Optimal age and strategy for screening hereditary hemochromatosis. The answers from a Markov decision process 124
Statistical methods to detect immune responses to drug administration 124
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 124
Leveraging Two-Stage delta Global Sensitivity Analysis method to inform parameter estimation in PBPK models 123
Online Microreactor Titanium Dioxide RPLC-LTQ-Orbitrap MS Automated Platform for Shotgun Analysis of (Phospho) Proteins in Human Amniotic Fluid 123
Precedence Temporal Networks: Extraction and Representation of Temporal Relationships in Gene Expression Profiles 122
CTRL + E.: Signalling is Nothing Without Control 122
Artificial intelligence and machine learning: just a hype or a new opportunity for pharmacometrics? 122
Accurate peak list extraction from proteomic mass spectra for identification and profiling studies 122
Characterization of promoter strength at different DNA copy numbers using RPU approach 121
Automatic translation of Bayesian pharmacometric models: the PharmML-to-WinBugs converter 121
Methods for genetic optimization of biocatalysts for biofuel production from dairy waste through synthetic biology 121
A Synthetic Close-Loop Controller Circuit for the Regulation of an Extracellular Molecule by Engineered Bacteria 121
Qualitative Representation and Clustering of Biomedical Time Series 120
MsPI: a tool for the analysis of peptide mass fingerprinting data 120
Mathematical modeling of growth and death dynamics of mouse embryonic stem cells irradiated with gamma-rays 120
PREDICTIVE METHOD FOR DETERMINING THE PATHOGENICITY OF COMBINATIONS OF DIGENIC OR OLIGOGENIC VARIANTS 119
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 119
A metabolic engineering approach to improve ethanol production from dairy waste by optimized Escherichia coli 119
Clustering bayesiano di serie temporali di espressione genica 118
MsPI: A software tool for protein identification by PMF 118
BioBrick, standard assembly e registro delle parti biologiche standard 118
Tumor growth modelling for drug development 118
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 118
A Bioinformatic Pipeline Supporting the Selection of Bacterial Promoters with Target Features from the Analysis of Transcriptomic Data 117
Totale 13.837
Categoria #
all - tutte 165.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.727 0 0 91 26 23 39 52 126 95 48 297 930
2022/20235.952 651 527 83 416 567 520 17 328 2.564 36 137 106
2023/20242.397 227 459 106 163 169 505 133 171 31 64 115 254
2024/20256.165 122 590 193 202 219 225 260 412 1.536 198 707 1.501
2025/202614.935 1.263 1.168 1.866 1.775 1.959 664 2.563 553 1.227 1.043 419 435
2026/20271.014 216 692 106 0 0 0 0 0 0 0 0 0
Totale 41.807